1.465
Tela Bio Inc Borsa (TELA) Ultime notizie
Insider Traders Lose US$143k As TELA Bio Drops - simplywall.st
TELA Bio’s SWOT analysis: biologic innovator’s stock faces growth hurdles By Investing.com - Investing.com South Africa
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates - MSN
Tela Bio at Canaccord Conference: Strategic Growth in Soft Tissue Repair - Investing.com Canada
Tela Bio reiterates $85M–$88M 2025 revenue target as international expansion accelerates - MSN
TELA Bio Awards Inducement Equity Grants to New Employees - MSN
Will TELA Bio Inc. stock benefit from AI tech trendsSwing Entry Risk Mitigation with Chart Analysis - Newser
TELA Bio Inc. stock trend forecastDaily Breakout List with Smart Filters - Newser
Tools to assess TELA Bio Inc.’s risk profileAI Stock Movement Forecast with Accuracy - Newser
Can trapped investors hope for a rebound in TELA Bio Inc.Free Strong Buy With Technical Confidence - Newser
Tela Bio shares fall 6.88% after-hours following inducement grants to new employees. - AInvest
TELA Bio 2025 Q2 Earnings Net Loss Narrows Amid Revenue Growth - AInvest
TELA Bio Reports Strong Q2 2025 Financial Results - MSN
Is TELA Bio Inc. forming a bottoming baseRetirement Investment Outlook and Return Summary - Newser
TELA Bio Inc (TELA) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
TELA Bio Inc (TELA) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
TELA Bio Reports Strong Q2 2025 Growth - TipRanks
TELA Bio Reports Second Quarter 2025 Financial Results - GlobeNewswire
TR | OpenAI4o Maintains TELA Bio(TELA.US) With Hold Rating, Maintains Target Price $2 - 富途牛牛
TELA Bio’s Revenue Climbed But Fell Short Of Expectations - Finimize
Contradictions Unveiled: TELA Bio's Q2 2025 Earnings Call Highlights Shifts in Sales Strategy, Product Growth, and Pricing Positioning - AInvest
Tela Bio (TELA): A Compelling Post-Earnings Case for Long-Term Value Creation in a High-Growth MedTech Sector - AInvest
Tela Bio's 2025 Revenue Guidance and Global Expansion: A Strategic Inflection Point for Scalable Growth - AInvest
Earnings call transcript: Tela Bio Q2 2025 sees stock rise despite EPS miss - Investing.com Canada
Tela Bio earnings missed by $0.04, revenue fell short of estimates - Investing.com Canada
Intraday pattern recognizer results for TELA Bio Inc.Daily Stock Watch Summary with Key Insights - Newser
TELA Bio's Q2 Revenue Miss: A Crossroads of Short-Term Pressures and Long-Term R&D Promise in Biotech - AInvest
TELA Bio misses Q2 revenue estimates - MarketScreener
What machine learning models say about TELA Bio Inc.Predicted Market Direction Based on Momentum - Newser
How to use a screener to detect TELA Bio Inc. breakoutsHigh Probability Trade Outcome Prediction - Newser
Is TELA Bio Inc. Stock Overbought or Oversold RSI Indicator AnalysisAI Generated Momentum Stock Forecast Guide - Newser
Using flow based indicators on TELA Bio Inc.Technical Safety Zone Pattern Recognition - Newser
Published on: 2025-08-09 23:56:57 - Newser
TELA Bio (TELA) Projected to Post Earnings on Monday - Defense World
TELA Bio's Equity Strategy: Balancing Talent Retention and Shareholder Value in the MedTech Sector - AInvest
TELA Bio Inc Q2 2025 Earnings Report Preview: Revenue Expected to Reach $20.68 Million, Earnings at -$0.18 per Share. - AInvest
TELA Bio Grants Inducement Stock Units to New Employees - AInvest
TELA Bio TELA 2025Q2 Earnings Preview Upside Potential Driven by Product Expansion - AInvest
TELA Bio Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):